Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Journey Medical (DERM) Shares Outstanding (Weighted Average): 2020-2024

Historic Shares Outstanding (Weighted Average) for Journey Medical (DERM) over the last 5 years, with Dec 2024 value amounting to $20.9 million.

  • Journey Medical's Shares Outstanding (Weighted Average) rose 17.61% to $24.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $24.4 million, marking a year-over-year increase of 17.61%. This contributed to the annual value of $20.9 million for FY2024, which is 12.87% up from last year.
  • Journey Medical's Shares Outstanding (Weighted Average) amounted to $20.9 million in FY2024, which was up 12.87% from $18.5 million recorded in FY2023.
  • In the past 5 years, Journey Medical's Shares Outstanding (Weighted Average) registered a high of $20.9 million during FY2024, and its lowest value of $15.8 million during FY2020.
  • In the last 3 years, Journey Medical's Shares Outstanding (Weighted Average) had a median value of $18.5 million in 2023 and averaged $19.0 million.
  • Data for Journey Medical's Shares Outstanding (Weighted Average) shows a peak YoY climbed of 12.87% (in 2024) over the last 5 years.
  • Journey Medical's Shares Outstanding (Weighted Average) (Yearly) stood at $15.8 million in 2020, then rose by 5.58% to $16.7 million in 2021, then grew by 6.27% to $17.7 million in 2022, then climbed by 4.54% to $18.5 million in 2023, then grew by 12.87% to $20.9 million in 2024.